Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis

Date: November 22, 2011
Pages: 38
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TB522C21154EN

Download PDF Leaflet

Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis
Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis


GlobalData’s report, 'Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis” provides key information, analysis on research studies and companies with their exhibited products at the TCT 2011 Conference. The report provides the highlights of the meeting, presentations, market dynamics and key participants with description on their exhibited products.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

  • Key players and their exhibited products.
  • Qualitative analysis on key research presentations and its impact on the market.

Reasons to buy
  • Develop business strategies by understanding the activities and developments at TCT 2011 Conference that can have an impact on the market.
  • Design and develop your product development, marketing and sales strategies
  • Exploit M&A opportunities by identifying key market players and their products
  • Develop market-entry and market expansion strategies
  • Identify key players best positioned to take advantage of the market opportunities


2.1 PARTNER Cohort B Two-Year Results Support Use of TAVR for Patients with Severe Aortic Stenosis who are Inoperable
2.2 PARTNER Cohort A QOL - Clinical Evidence shows Improved QOL with TAVR with Transfemoral Approach
2.3 PARTNER Cohort A CE: Cost-Effectiveness Analysis from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement in High-Surgical-Risk Patients with Aortic Stenosis
2.4 New Data Reinforces Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold
2.5 Boston Scientific’s SYNERGY Stent Demonstrates Comparable Safety and Effectiveness Outcomes Versus PROMUS Element Platinum Chromium Stent
2.6 Boston Scientific's PROMUS Element Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients with Long Coronary Lesions
2.7 Boston Scientific's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program
2.8 Boston Scientific's Carotid WALLSTENT Monorail Endoprosthesis Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice
2.9 Medtronic’s Resolute Drug-Eluting Stent Shows Strong Results, even in Challenging Diabetes Patients with Coronary Disease
2.10 Medtronic's Endeavor Drug-Eluting Stent Demonstrates Long-Term Advantages over Taxus DES
2.11 BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon
2.12 MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for CARDIOSAVE Intra-Aortic Balloon Pump
2.13 CryoPlasty Therapy with Boston Scientific’s PolarCath Dilatation System Reduces Restenosis Rates by Nearly 50% in Peripheral Stenting Procedures
2.14 Tryton Announces Successful Live Case Transmission on Tryton Side Branch Stent
2.15 St. Jude’s Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study
2.16 New Data Confirms Early Implantation of Abiomed’s Impella 2.5 prior to PCI Improves Survival in Shock Patients
2.17 BioFreedom FIM Trial Demonstrates Comparable Long-Term Safety and Efficacy to Conventional Drug-Eluting Stent
2.18 Genous Stent Demonstrates most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation
2.19 Carotid Artery Stenting Possible for High Risk Patients with Lesions
2.20 ADP Antagonists found to be Significant Predictors of Stent Thrombosis within 30 Days
2.21 Risk of Late Thrombosis for First Generation DES found to Continue for up to Seven Years
2.22 Coronary Thrombectomy in Conjunction with Percutaneous Coronary Intervention Can Improve the Rates of ST-Segment Elevation Resolution
2.23 Non-Adherence to Anti-Platelet Regimens in Stented Patients Leads to Higher Rates of both Ischemic and Bleeding Events at 30 Days
2.24 TAVI found Unsafe Compared to SAVR in Elderly Patients in Preliminary Results
2.25 Transradial Approach Found to be Effective for Patients with ST Elevation Acute Coronary Syndrome
2.26 Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System


3.1 Abbott Laboratories
  3.1.1 Absorb
  3.1.2 MitraClip System
  3.1.3 XIENCE PRIME Everolimus Eluting Coronary Stent System
3.2 Abiomed, Inc
  3.2.1 Impella LP 2.5 - PCI
3.3 Biosensors International Group, Ltd
  3.3.1 AXXESS Biolimus A9 Eluting Bifurcation Stent System
  3.3.2 BioFreedom
  3.3.3 BioMatrix Flex Drug Eluting Stent
  3.4.1 PRO-Kinetic Energy Stent System
  3.4.2 Pantera LUX Paclitaxel Releasing Balloon
3.5 Boston Scientific
  3.5.1 SYNERGY Coronary Stent
3.6 Cappella Inc.
  3.6.1 Sideguard
3.7 Cardiac Dimensions
  3.7.1 CARILLON Mitral Contour System
3.8 Cardiovascular Systems, Inc
  3.8.1 Diamondback 360° - Calcified Coronary Lesions
3.9 Corindus, Inc.
  3.9.1 CorPath 200 Robotic PCI System
3.10 Edwards Lifesciences Corporation
  3.10.1 Edwards SAPIEN Transcatheter Heart Valve - RetroFlex 3 Delivery System
3.11 Flexible Stenting Solutions, Inc
  3.11.1 Carotid Stent
  3.11.2 FlexStent Femoropopliteal Self Expanding Stent System
  3.11.3 Tibial SE FlexStent
3.12 InfraReDx, Inc.
  3.12.1 TVC Imaging System
3.13 InSeal Medical Ltd.
  3.13.1 InSeal Intravascular Closure Device
3.14 InspireMD Ltd.
  3.14.1 MGuard
3.15 Lake Region Medical
  3.15.1 Anchorwire Guidewires
  3.15.2 TRAILRUNNER Guidewires
  3.16.1 Cardiosave Intra-Aortic Balloon Pump (IABP)
3.17 MEDRAD, Inc
  3.17.1 Next Generation Cotavance
3.18 Medtronic
  3.18.1 23 Millimeter CoreValve on a 16 French Delivery System
  3.18.2 26 Millimeter CoreValve System
  3.18.3 29 Millimeter CoreValve System
  3.18.4 31 Millimeter CoreValve System
  3.18.5 Endeavor Resolute
  3.18.6 Assurant Cobalt Iliac Balloon-Expandable Stent System
  3.18.7 Complete SE (Self-Expandable) Vascular Stent System
  3.18.8 IN.PACT Admiral Drug Eluting Balloon
  3.18.9 IN.PACT Amphirion Paclitaxel Eluting Balloon Catheter
  3.18.10 IN.PACT Falcon PTCA Balloon Catheter
  3.18.11 IN.PACT Pacific Balloon Catheter
  3.18.12 Endurant AAA Stent Graft System
  3.18.13 Symplicity Catheter System
3.19 Micell Technologies, Inc.
  3.19.1 MiStent DES
3.20 OrbusNeich
  3.20.1 Combo Bio-Engineered Sirolimus Eluting Stent
  3.20.2 Genous Bio-Engineered R Stent
3.21 REVA Medical, Inc.
  3.21.1 ReZolve Bioresorbable Coronary Stent
3.22 Sunshine Heart Company, Pty. Ltd.
  3.22.1 C-Pulse Heart Assist System
3.23 Svelte Medical Systems
  3.23.1 Acrobat Stent-on-a-Wire Sirolimus Drug Eluting Stent
3.24 Tryton Medical, Inc
  3.24.1 TRYTON Side Branch Stent System
3.25 Volcano Corporation
  3.25.1 Eagle Eye Gold IVUS Imaging Catheter
  3.25.2 Eagle Eye Platinum Digital IVUS Catheter
  3.25.3 PrimeWire PRESTIGE Plus Pressure Guide Wire Device
  3.25.4 Volcano s5/s5i Intravascular Ultrasound Imaging System
  3.25.5 FL.IVUS Imaging System
  3.25.6 Forward Looking ICE
  3.25.7 Impact Micro-Catheter
  3.25.8 LVOCT System
  3.25.9 NC VIBE Imaging Balloon Catheter
  3.25.10 Next Generation Phased Array IVUS Catheter
  3.25.11 Next Generation Revolution Catheter
  3.25.12 Preview Forward Looking IVUS Catheter & System
  3.25.13 VALET Micro-Catheter
  3.25.14 VIBE RX Vascular Imaging Balloon Catheter
  3.25.15 Volcano OCT System
  3.25.16 Volcano-Xtract Thrombectomy Catheter
3.26 Disclaimer


Abbott Laboratories
Abiomed, Inc
Biosensors International Group, Ltd
Boston Scientific
Cappella Inc.
Cardiac Dimensions
Cardiovascular Systems, Inc
Corindus, Inc.
Edwards Lifesciences Corporation
Flexible Stenting Solutions, Inc
InfraReDx, Inc.
InSeal Medical Ltd.
InspireMD Ltd.
Lake Region Medical
Micell Technologies, Inc.
REVA Medical, Inc.
Sunshine Heart Company, Pty. Ltd.
Svelte Medical Systems
Tryton Medical, Inc
Volcano Corporation
Skip to top

Ask Your Question

Transcatheter Cardiovascular Therapeutics (TCT) Conference 2011 - Review and Analysis
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: